QuiaPEG Pharmaceuticals Holding AB - Asset Resilience Ratio

Latest as of March 2017: 14.02%

QuiaPEG Pharmaceuticals Holding AB (QUIA) has an Asset Resilience Ratio of 14.02% as of March 2017. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See QUIA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Skr3.36 Million

≈ $361.83K USD Cash + Short-term Investments

Total Assets

Skr23.99 Million

≈ $2.58 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2010)

This chart shows how QuiaPEG Pharmaceuticals Holding AB's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see QUIA current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down QuiaPEG Pharmaceuticals Holding AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read total liabilities of QuiaPEG Pharmaceuticals Holding AB for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr3.36 Million	14.02%
Total Liquid Assets	Skr3.36 Million	14.02%

Asset Resilience Insights

Moderate Liquidity: QuiaPEG Pharmaceuticals Holding AB has 14.02% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

QuiaPEG Pharmaceuticals Holding AB Industry Peers by Asset Resilience Ratio

Compare QuiaPEG Pharmaceuticals Holding AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for QuiaPEG Pharmaceuticals Holding AB (2010–2010)

The table below shows the annual Asset Resilience Ratio data for QuiaPEG Pharmaceuticals Holding AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2010-12-31	24.43%	Skr4.86 Million ≈ $522.48K	Skr19.88 Million ≈ $2.14 Million	--

pp = percentage points

About QuiaPEG Pharmaceuticals Holding AB

ST:QUIA Sweden Biotechnology

Market Cap

$141.00K

Skr1.31 Million SEK

Market Cap Rank

#31411 Global

#739 in Sweden

Share Price

Skr0.00

Change (1 day)

-16.67%

52-Week Range

Skr0.00 - Skr0.00

All Time High

Skr464.25